Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer’s and other dementias.
365Daily.net
365Daily.net
Bipartisan legislators introduced the ASAP Act to authorize Medicare coverage for FDA-approved blood-based biomarker tests aimed at the early detection of Alzheimer’s and other dementias.
